NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

細胞治療細胞凍結用培養基的全球市場:2020年∼2027年

Global Cell Freezing Media For Cell Therapy Market, Size, Share, Opportunities and Forecast, 2020-2027

出版商 DataM Intelligence 商品編碼 985567
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
細胞治療細胞凍結用培養基的全球市場:2020年∼2027年 Global Cell Freezing Media For Cell Therapy Market, Size, Share, Opportunities and Forecast, 2020-2027
出版日期: 2021年04月03日內容資訊: 英文 180 Pages
簡介

全球細胞治療細胞凍結用培養基市場,由於製藥、生物醫藥品市場區隔的研究的政府舉措擴大,預計促進全球的市場成長。

本報告提供全球細胞治療細胞凍結用培養基市場相關調查分析,產業分析,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 全球細胞治療細胞凍結用培養基市場調查手法與調查範圍

第2章 全球細胞治療細胞凍結用培養基市場:市場定義與市場概要

第3章 全球細胞治療細胞凍結用培養基市場:摘要整理

第4章 全球細胞治療細胞凍結用培養基市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 機會
    • 影響分析

第5章 全球細胞治療細胞凍結用培養基市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求
  • 專利趨勢

第6章 全球細胞治療細胞凍結用培養基市場:COVID-19分析

  • 對市場的COVID-19分析
  • COVID-19的價格趨勢
  • 供需頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球細胞治療細胞凍結用培養基市場:培養基的各類型

  • 簡介
  • 市場規模分析、與前一年同期比較成長率分析:培養基的各種類市場區隔
  • 市場魅力指數:培養基的各種類市場區隔
    • 有FBS
    • 沒有FBS

第8章 全球細胞治療細胞凍結用培養基市場:各用途

  • 簡介
  • 市場規模分析、與前一年同期比較成長率分析:各用途市場區隔
  • 市場魅力指數:各用途市場區隔
    • 人類胚胎幹細胞
    • CAR-T細胞療法
    • 神經幹細胞療法
    • 間質幹細胞療法
    • 造血幹細胞移植
    • 其他

第9章 全球細胞治療細胞凍結用培養基市場:各地區

  • 簡介
  • 市場規模分析、與前一年同期比較成長率分析:各地區
  • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第10章 全球細胞治療細胞凍結用培養基市場:競爭情形

  • 競爭模式
  • 市場定位/佔有率分析
  • M&A分析

第11章 全球細胞治療細胞凍結用培養基市場:企業簡介

  • BioLifeSolutions, Inc.
  • HiMedia Laboratories
  • Miltenyi Biotec
  • Mediatech, Inc.
  • Nippon Genetics
  • PromoCell GmbH
  • General Electric Company
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Zenoaq
  • 其他企業

第12章 全球細胞治療細胞凍結用培養基市場:重要考察

第13章 全球細胞治療細胞凍結用培養基市場:DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global Cell Freezing Media For Cell Therapy Market is segmented By Type of Media (With FBS, Without FBS), By Application (Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Cell Freezing Media For Cell Therapy Market is expected to grow at a CAGR of 13.3% during the forecasting period (2020-2027).

The cell freezing medium should contain a cryoprotective agent, such as dimethylsulfoxide (DMSO) or glycerol. It is a complete cell freezing media, especially for mammalian cell cultures. However, since it is known that DMSO is a carcinogen and mutagen, DMSO-free formulations are becoming popular for the applications of stem cells. This is an especially critical issue for cells being used in translational research or clinical applications.

Source: DataM Intelligence Analysis (2019)

Market Dynamics:

Growing government initiatives for research in the pharmaceutical and biopharmaceutical segment are expected to drive the market's growth across the globe. Moreover, the advantages of cell freezing for storage in drug development or other programs are likely to stimulate the market's growth. However, high maintenance cost in storage procedure is the major factor that can hamper the market's growth during the forecast period.

R&D in personalized medicine leads the market's growth

Investment in R&D of cell culture for the development of personalized medicines has increased significantly from past years. Numerous companies are investing in cell culture technology; thereby, creating an opportunity for the market's growth shortly. This increased use of harvesting in cell culture to treat numerous diseases is expected to promote the market's growth shortly. All such advances in technology and increasing expenditure in R&D are expected to propel the market's growth over the coming years.

Recognition of cell culture in various healthcare diseases

The increasing recognition of cell culture in cancer treatment, drug discovery, and vaccine production has boosted cell-based research funding. However, the funds required for cell-based research are very high, due to which funding for these researches has been encouraged in a very few developed nations such as the US and UK. As the funding for cell-based research increases, the opportunities for augmentation of the cell harvesting market are expected to increase significantly shortly.

COVID-19 Impact Analysis

The COVID-19 pandemic outbreak is expected to derail the cell freezing media's growth for the cell therapy market in 2020. The decline in the research activities in the cell culture technology and shift towards the development of COVID-19 vaccines is the major factor that has negatively impacted the cell freezing media for cell therapy market growth in 2020.

Segment Analysis

By application, the cell freezing media for the cell therapy market is classified into human embryonic stem cells, CAR-T cell therapy, neural stem cell therapy, mesenchymal stem cell therapy, hematopoietic stem cell transplantation, and others.

Human Embryonic Stem Cells segment to dominate global cell freezing media for cell therapy market

Embryonic stem cells are termed as the pluripotent cell lines obtained from the blastocyst-stage early mammalian embryo. These unique cells are described by their capacity for the lengthy homogenous rise in culture while maintaining the potential to differentiate into byproducts. During in vitro differentiation, embryonic stem cells can grow into specialized somatic cells, including cardiomyocytes, and have been shown to run through many processes of early embryonic development.

The cell freezing media for the cell therapy market is classified into FBS and without FBS by media type.

FBS leads the growth of the market 

The medium used to cryopreserve cells should always be the same formulation as that used to propagate the cells with the addition of fetal bovine serum (FBS) (in the case of serum-free cultures) or the increase in the concentration of FBS but to a final concentration of no more than 20%. The FBS will bind toxic materials that may be released if some cells are lysed during the freezing or thawing process.

Source: DataM Intelligence Analysis (2019)

Geographical Analysis

North America dominated the global market throughout the forecast period.

The North American market dominated the largest market share in the global cell freezing media for the cell therapy market in 2019. The U.S. contributed the major share of over 87.0% in the North America cell freezing media for cell therapy market in 2019. North America has a well-developed healthcare infrastructure. The companies are investing in developing advanced solutions for the cell freezing media for the cell therapy market. A sedentary lifestyle and unhealthy dietary habits are prime factors for increasing chronic diseases such as diabetes and cardiovascular diseases. The research institutes are developing effective treatment solutions for these diseases. This growth in the R&D activities offers growth to the cell freezing media for the region's cell therapy market.

Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally due to the increasing prevalence of chronic diseases such as cancer in the region, especially in China and India. The growing spending on establishing advanced healthcare facilities in emerging economies, such as China, and collaboration among the market players to develop innovative products contribute significantly to the market growth.  

Competitive Landscape

The cell freezing media for the cell therapy market is dominating by a few companies. Some of the key players in the market's growth include BioLifeSolutions, Inc., HiMedia Laboratories, Miltenyi Biotec, Mediatech, Inc., General Electric Company, PromoCell GmbH, Merck KGaA, and Nippon Genetics, among others. The key players execute several growth strategies such as product launches, acquisitions, and collaborations, which are estimated to boost the cell freezing media for cell therapy market growth globally.  

GE Healthcare

Overview: GE Healthcare operates as a subsidiary of General Electric Co. in Chicago, the US, since its inception in 1994. As of 2019, the company had more than 56,000 employees across over 180 countries. The company registered revenue of approximately $20  billion in 2019. The company's portfolio contains a range of products, solutions, and services to diagnose, treat, and monitor patients. In addition to this, the company is also focused on the development and manufacturing of biopharmaceuticals.

Product Type Portfolio: The company's portfolio comprised the cryopreservation of cellular materials.

Why Purchase the Report?

Visualize the cell freezing media composition for cell therapy market segmentation by type of media, application, and region, highlighting the key commercial assets and players.

Identify commercial opportunities in cell freezing media for the cell therapy market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of cell freezing media for cell therapy market - level 2 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players.

The global cell freezing media for cell therapy market report would provide access to an approx. 48 market data tables, 45 figures, and 263 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Related Topic's

Japan Cell Therapy Market

Gene Therapy Market

Oncology Therapy Market

Table of Contents

Table of Contents

Cell Freezing Media for Cell Therapy Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

Cell Freezing Media for Cell Therapy Market - Market Definition and Overview

Cell Freezing Media for Cell Therapy Market - Executive Summary

Market Snippet by Type of Media

Market Snippet By Application

Market Snippet by Region

Cell Freezing Media for Cell Therapy Market-Market Dynamics

Market Impacting Factors

Drivers

Rising R&D in cell culture

Increasing government spending in research processes

Restraints:

High research cost

Opportunity

Impact Analysis

Cell Freezing Media for Cell Therapy Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Value Chain Analysis

PEST Analysis

Pricing Analysis

Regulatory Analysis

Reimbursement Analysis

Unmet Needs

Patent Trends

Cell Freezing Media for Cell Therapy Market - COVID-19 Analysis

Analysis of Covid-19 on the Market

Before COVID-19 Market Scenario

Present COVID-19 Market Scenario

After COVID-19 or Future Scenario

Pricing Dynamics Amid Covid-19

Demand-Supply Spectrum

Government Initiatives Related to the Market During Pandemic

Manufacturers Strategic Initiatives

Conclusion 

Cell Freezing Media for Cell Therapy Market - By Type of Media

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Media Segment

Market Attractiveness Index, By Type of Media Segment

With FBS

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Without FBS

Cell Freezing Media for Cell Therapy Market - By Application

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment

Market Attractiveness Index, By Application Segment

Human Embryonic Stem Cells

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

CAR-T Cell Therapy

Neural Stem Cell Therapy

Mesenchymal Stem Cell Therapy

Hematopoietic Stem Cell Transplantation

Others

Cell Freezing Media for Cell Therapy Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Media

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

The U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Media

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

The U.K.

France

Italy

Spain

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Media

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Media

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

The Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Media

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Cell Freezing Media for Cell Therapy Market - Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

Cell Freezing Media for Cell Therapy Market- Company Profiles

BioLifeSolutions, Inc.*

Company Overview

Product Portfolio and Description

Key Highlights

Financial Overview

HiMedia Laboratories

Miltenyi Biotec

Mediatech, Inc.

Nippon Genetics

PromoCell GmbH

General Electric Company

Merck KGaA

Thermo Fisher Scientific, Inc.

Zenoaq

Other Companies

Cell Freezing Media for Cell Therapy Market - Premium Insights

Cell Freezing Media for Cell Therapy Market - DataM Intelligence

Appendix

About Us and Services

Contact Us

Suggestions for Related Market Report:

3D Cell Culture Market

Cell Culture Market

Stem Cell Therapy Market

Cell Harvesting Market